Virulence markers and antimicrobial susceptibility of bacteria of the Bacteroides fragilis group isolated from stool of children with diarrhea in São Paulo, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 3, 2004, Pages 307-312

  Nakano, Viviane ^a   Avila Campos, Mario J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimicrobial resistance; Bacteroides fragilis; Enterotoxigenic Bacteroides fragilis; Pathogenesis; Plasmid

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ARABINOSE; CEFOXITIN; CLINDAMYCIN; ENTEROTOXIN; ERYTHROMYCIN; FRAGILYSIN; GALACTOSE; IMIPENEM; LEAD; MANNOSE; METRONIDAZOLE; NICKEL; PENICILLIN G; TETRACYCLINE; XYLOSE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DIARRHEA; ENZYME ACTIVITY; ERYTHROCYTE; FECES ANALYSIS; HEAT TOLERANCE; HEMAGGLUTINATION; HUMAN; HUMAN CELL; INFANT; PLASMID; PRESCHOOL CHILD;

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES UNIFORMIS;

EID: 3042612191     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000300012     Document Type: Article

References (38)

1. Avila-Campos MJ 1995. Haemolytic activity of Actinobacillus actinomycetemcomitans strains on different blood types. Rev Inst Med Trop 37: 215-217.
2. Avila-Campos MJ, Carvalho MAR, Damasceno CAV, Chartone-Souza E, Cisalpino EO 1991. Population stability in species of the Bacteroides fragilis group, under mercuric chloride action. Rev Microbiol 22: 93-96.
3. Beul HA, von Eicher-Streiber C, Schreiner M, Schwindling FP, Weinblum D, Zöllner EJ, Dierich M 1985. Characterization of cryptic plasmids in clinical isolates of Bacteroides fragilis. J Med Microbiol 20: 39-48.
4. Bressane MA, Durigon LE, Avila-Campos MJ 2001. Prevalence of the Bacteroides fragilis group and enterotoxenic Bacteroides fragilis in immunodeficient children. Anaerobe 7: 277-281.
5. Cáceres M, Zhang G, Weintraub A, Nord CE 2000. Prevalence and antimicrobial susceptibility of enterotoxigenic Bacteroides fragilis in children with diarrhea in Nicaragua. Anaerobe 6: 143-148.
6. Carvalho CB, Moreira JL, Ferreira MCS 1997. Survey of Bacteroides fragilis group susceptibility patterns in Brazil. Int J Antimicrob Agents 8: 115-120.
7. Domingues RMCP, Cavalcanti SMB, Fonseca MEF, Ferreira MCS 1991. Hemagglutination activity of Bacteroides fragilis as a virulence marker. Rev Microbiol 22: 277-281.
8. Domingues RMCP, Oliveira M, Hirata RJ, Andrade AFB, Ferreira MCS 1995. Bacteroides fragilis: an exogenous pathogen? Zbl Bakt 282: 296-302.
9. Duerden BI 1980. The isolation and identification of Bacteroides spp. from the normal human faecal flora. J Med Microbiol 13: 69-78.
10. Ferreira R, Alexandre MCF, Antunes ENF, Pinhão AT, Moraes SR, Ferreira MCS, Domingues RMCP 1999. Expression of Bacteroides fragilis virulence markers in vitro. J Med Microbiol 48: 999-1004.
11. Franco AA, Mundy LM, Trucksis M, Wu S, Kaper JB, Sears CL 1997. Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect Immun 65: 1007-1013.
12. Gorbach SL, Bartlett JG 1974. Anaerobic infections. N Engl J Med 290: 1177-1184.
13. Holdeman LV, Cato EP, Moore WE 1977. Anaerobic Laboratory Manual, 4th ed., Virginia Polytechnic Institute, Blackburg, VA.
14. Kasper DL, Hayes ME, Reinap BG, Craft FO, Onderdonk AB, Polk BF 1977. Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis 136: 75-81.
15. Kalo N, Liu CX, Kato H, Watanabe K, Tanaka Y, Yamamoto T, Suzuki K, Ueno K 2000. A new subtype of the metalloprotease toxin gene and the incidence of the three bft subtypes among Bacteroides fragilis isolates in Japan. FEMS Microbiol Letts 182: 171-176.
16. Koshy SS, Montrose MH, Sears CL 1996. Human intestinal epithelial cells swell and demonstrate actin rearrangement in response to the metalloprotease toxin of Bacteroides fragilis. Infect Immun 64: 5022-5028.
17. Krzyzanowsky F, Avila-Campos MJ 2003. Detection of non-enterotoxigenic and enterotoxigenic Bacteroides fragilis in stool samples from children in São Paulo, Brazil. Rev Inst Med Trop São Paulo 45: 225-227.
18. Lindberg AA, Weintraub A 1985. Encapsulation and protection against phagocytosis by Bacteroides fragilis. Scand J Infect Dis S46: 27-32.
19. Moncrief JS, Obiso RJ, Barroso LA, Kling JJ, Wright RL, Van Tassel, RL, Lyerly DM, Wilkins TD 1995. The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun 63: 175-181.
20. Myers LL, Firehammer BD, Shoop DS, Border MM 1984. Bacteroides fragilis: a possible cause of acute diarrheal disease in newborn lambs. Infect Immun 44: 241-244.
21. Namavar F, Marian A, Verweij-Van Vught JJ, Maclaren DM 1991. A study of the candidate virulence factors of Bacteroides fragilis. J Gen Microbiol 137: 1431-1435.
22. NCCLS-1997. National Committee for Clinical Laboratory Standard Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 4th ed. Approved Standard. NCCLS document M11-A4. National Committee for Clinical Laboratory Standards, Wayne, PA.
23. Oyston PC, Handley PS 1990. Surface structures, haemagglutination and cell surface hydrophobicity of Bacteroides fragilis strains. J Gen Microbiol 136: 941-948.
24. Pantosti A, Cerquetti M, Colangeli R, D'Ambrosio F 1994. Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by HT-29 cytotoxicity assay. J Med Microbiol 41: 191-196.
25. Pantosti A, Malpeli M, Wilks M, Menozzi MG, D'Ambrosio F 1997. Detection of enterotoxigenic Bacteroides fragilis by PCR. J Clin Microbiol 35: 2482-2486.
26. Pestana ACNR, Diniz CG, Farias LM, Carvalho MAR 1999. Plasmid-related resistance to clindamycin and penicillin G in a Bacteroides vulgatus strain. Anaerobe 5: 447-449.
27. Riley TV, Mee BJ 1982. Susceptibility of Bacteroides spp. to heavy metals. Antimicrob Agents Chemother 22: 889-892.
28. Rosenberg M, Perry A, Bayer EA, Gutnick DL, Rosenberg M, Ofek I 1981. Adherence of Acinetobacter calcoaceticus RAG-1 to human epithelial cells and to hexadecane. Infect Immun 33: 29-33.
29. Rotimi VO, Eke PI 1984. The bactericidal action of human serum on Bacteroides species. J Med Microbiol 18: 355-363.
30. Smith JC, Parker AC 1996. A gene product related to Tral is required for the mobilization of Bacteroides mobilizable transposons and plasmids. Mol Microbiol 20: 741-750.
31. Snydman DR, McDermott L, Cuchural GL, Hecht DW, Iannini PB, Harrell LJ, Jenkins SG, O'Keefe JP, Pierson CL, Rihs JD, Yu VL, Finegold SM, Gorbach SL 1996. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis 23 (Suppl. 1): S54-65.
32. Soki J, Szöke I, Nagy E 1999. Characterization of 5.5-kb cryptic plasmid present in different isolates of Bacteroides spp. originating from Hungary. J Med Microbiol 48: 25-31.
33. Sutter VL, Barry AL, Wilkins TD, Zabransky RL 1979. Collaborative evaluation of a proposed dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother 16: 495-502.
34. Tally FP, Syndman DR, Gorbach SL, Malamy MH 1979. Plasmid-mediated transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Infect Dis 139: 83-88.
35. Turner P, Edwards R, Weston V, Gazis A, Ispahani P, Greenwood D 1995. Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolates of B. fragilis. Lancet 345: 1275-1277.
36. Vel WAC, Navamar F, Marian A, Verweij-Van Vught JJ, Pubben ANB, Maclaren DM 1986. Haemagglutination by Bacteroides fragilis group. J Med Microbiol 21: 105-107.
37. Wallace BL, Bradley JE, Rogolsky M 1981. Plasmid analyses in clinical isolates of Bacteroides fragilis and other Bacteroides species. J Clin Microbiol 14: 383-388.
38. Welch RA, Jones KR, Macrina FL 1981. Transferable lincosamide-macrolide resistance in Bacteroides. Plasmid 2: 261-268.